• Thurs news: Lilly’s weight-loss drug prevents diabetes. Merck pays $588M for bispecific. Amgen speaks out about bone density issues with obesity drug. PTC gets gene therapy approval. JNJ’s 340B legal fight. See more on our front page

Optinose

Quote




























anonymous said:
Here the message: Sell or you are out!
Peter
Click to expand...

Hey Tom and Rahmy, Please do not let this guy out in the field. Every time he goes out and talks to a doc it's a change in direction and we have to re-prioritize and start doing things differently. Slow your roll and let things happen so we can get a sense of what is and isn't working. When Petey heads out in the field, we all know the shit is about to be stirred and we're going to have to start over with the crap that will be coming down based on one conversation with the CEO and a doc or a rep who tells him what he wants to hear.
 




Peter is an odd combination...book smart, but according to many, lacking a grasp of the real world. He certainly has chosen a motley crew to hire. Good thing they are all "nice". Hmmm... Nice is not the first word that comes to mind about a man in his late forties who advertises online for eighteen year old girls to date. Nice hiring choices there, Peter!!! Stellar VP material!
 




That is our observation, he is completely removed from reality.
Also has never actually launched any pharma products successfully.
Was an OTC guy at JNJ then was fired after being moved to the pharma division.
Ask him about it.
Then his buddy Tom has worked at about 9 companies in 10 years. Tells a big story and moves
on before being discovered.
Storm brewing ahead.
 




I suppose that explains why he is partial to hiring JNJ rejects. So between the two of them, they have not had any success in a product launch, and yet so many are imagining that this will be their "big score"... I don't know, but I'm with you, I think this is going to get really interesting, and sooner rather than later. I am however, scratching my head as to the resiliency of their stock price...based on what, I don't really understand. I'm no psychic, but I'm guessing when "the nose" goes down, it will do so quickly. Stay tuned I suppose!
 








My understanding is that there was initial curiosity, but not much beyond that. I'm wondering how long it will take before they start having serious concerns as to the viability of this company.
 












You may be in TROUBLE.....next up....the naughty chair...trust me when I tell you that somebody leaking sales numbers is going to be the LEAST of your problems....you might concern yourself with the reason why the sales numbers are so poor versus who is confirming everybody's suspicions....
 












anonymous said:
LMAO. Sounds like the sales force needs more GRIT.
Click to expand...

It gives me great pleasure to watch this dog crap pile get stepped on and stuck to your shoe. Your VP of Sales is getting what is called karma for how many times he treated people like shit in his career. Loving every minute of this!!! bahahahahahaha
 








Top Bottom
Back
Quote